A total of 96 Mergers & Acquisitions (M&A) deals (pending and completed) were announced in the Healthcare of China, in the last twelve months resulting in a total deal value of over $6,624.2 million. In the LTM period, June 2021 turned out to be the most prolific in terms of deal size, with a total deal value of $2,342.9 million, resulting in an average deal value of $292.9 million during that month. On the other hand, the month of August 2021 was the most prolific in terms of deal volume, recording a total of 20 deals, resulting in an average deal value of $26.5 million during that month.
Of the 96 deals, the deal secured between AIA Company Limited and China Post Life Insurance Company Ltd, was the largest M&A deal in the China Healthcare sector, which was valued at $1,860.0 million and was completed on June 29, 2021. The second-largest deal was between Shanghai Fosun Pharmaceutical (Group) Co Ltd and Chengdu Antkin Biotechnology Co Ltd, while the third-largest deal was between Demant A/S and Chengdu Prestige Yuanbo Hearing Aid Sales Co Ltd. The Shanghai Fosun Pharmaceutical (Group) Co Ltd-Chengdu Antkin Biotechnology Co Ltd deal and the Demant A/S-Chengdu Prestige Yuanbo Hearing Aid Sales Co Ltd deal were valued at $627.3 million and $259.5 million, respectively. The fourth-largest deal was between Tate & Lyle PLC-Quantum Hi-Tech (China) Biological Co Ltd valued at $237.0 million, whereas the deal between Tianjin KingYork Group Co., Ltd.,-Tianjin Pharmaceuticals Group Co Ltd valued at $220.1 million was the fifth-largest deal.
Cumulatively, the top five deals amounted to $3,204.0 million and accounted for nearly 48.37% of the total deals (by value) announced during the last twelve months.
United States of America
China
Switzerland
United States of America
United States of America
United States of America
United States of America
United States of America
United States of America
Japan
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer